Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease von Biegstraaten, M., Cox, T.M., Belmatoug, N., Berger, M.G., Collin-Histed, T., Vom Dahl, S., Di Rocco, M., Fraga, C., Giona, F., Giraldo, P., Hasanhodzic, M., Hughes, D.A., Iversen, P.O., Kiewiet, A.I., Lukina, E., Machaczka, M., Marinakis, T., Mengel, E., Pastores, G.M., Plöckinger, U., Rosenbaum, H., Serratrice, C., Symeonidis, A., Szer, J., Timmerman, J., Tylki-Szymańska, A., Weisz Hubshman, M., Zafeiriou, D.I., Zimran, A., Hollak, C.E.M.

Volltext

Comparing Effectiveness of Experimental and Implemented Bycatch Reduction Measures: the Ideal and the Real von COX, T.M, LEWISON, R.L, ŽYDELIS, R, CROWDER, L.B, SAFINA, C, READ, A.J

Volltext

An interview-based approach to assess marine mammal and sea turtle captures in artisanal fisheries von Moore, J.E., Cox, T.M., Lewison, R.L., Read, A.J., Bjorkland, R., McDonald, S.L., Crowder, L.B., Aruna, E., Ayissi, I., Espeut, P., Joynson-Hicks, C., Pilcher, N., Poonian, C.N.S., Solarin, B., Kiszka, J.

Volltext

B cell lymphoma and myeloma in murine Gaucher's disease von Pavlova, EV, Wang, SZ, Archer, J, Dekker, N, Aerts, JMFG, Karlsson, S, Cox, TM

Volltext

Sustained therapeutic effects of oral miglustat (Zavesca, N‐butyldeoxynojirimycin, OGT 918) in type I Gaucher disease von Elstein, D., Hollak, C., Aerts, J. M. F. G., Weely, S., Maas, M., Cox, T. M., Lachmann, R. H., Hrebicek, M., Platt, F. M., Butters, T. D., Dwek, R. A., Zimran, A.

Volltext

Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring von Cox, T. M., Aerts, J. M. F. G., Belmatoug, N., Cappellini, M. D., vom Dahl, S., Goldblatt, J., Grabowski, G. A., Hollak, C. E. M., Hwu, P., Maas, M., Martins, A. M., Mistry, P. K., Pastores, G. M., Tylki-Szymanska, A., Yee, J., Weinreb, N.

Volltext

The role of the iminosugar N‐butyldeoxynojirimycin (miglustat) in the management of type I (non‐neuronopathic) Gaucher disease: A position statement von Cox, T. M., Aerts, J. M. F. G., Andria, G., Beck, M., Belmatoug, N., Bembi, B., Chertkoff, R., Vom Dahl, S., Elstein, D., Erikson, A., Giralt, M., Heitner, R., Hollak, C., Hrebicek, M., Lewis, S., Mehta, A., Pastores, G. M., Rolfs, A., Sa Miranda, M. C., Zimran, A.

Volltext

Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease von Marchesan, D., Cox, T. M., Deegan, P. B.

Volltext

Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses von COX, T. M

Volltext

Twin pairs showing discordance of phenotype in adult Gaucher's disease von Lachmann, R.H., Grant, I.R., Halsall, D., Cox, T.M.

Volltext

Acute intermittent porphyria: fatal complications of treatment von Stein, PE, Badminton, MN, Barth, JH, Rees, DC, Sarkany, R, Stewart, MF, Cox, TM

Volltext

Juvenile Hemochromatosis Locus Maps to Chromosome 1q von Roetto, A., Totaro, A., Cazzola, M., Cicilano, M., Bosio, S., D'Ascola, G., Carella, M., Zelante, L., Kelly, A.L., Cox, T.M., Gasparini, P., Camaschella, C.

Volltext

Monitoring enzyme replacement therapy in Fabry disease—Role of urine globotriaosylceramide von Whitfield, P. D., Calvin, J., Hogg, S., O'Driscoll, E., Halsall, D., Burling, K., Maguire, G., Wright, N., Cox, T. M., Meikle, P. J., Deegan, P. B.

Volltext

Quantifying the Erlenmeyer flask deformity von CARTER, A, RAJAN, P. S, DEEGAN, P, COX, T. M, BEARCROFT, P

Volltext

Substrate reduction therapy for lysosomal storage diseases von Cox, T M

Volltext

Mice lacking tartrate‐resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus von Bune, A. J., Hayman, A. R., Evans, M. J., Cox, T. M.

Volltext

Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10 von Allen, M.J., Myer, B.J., Khokher, A.M., Rushton, N., Cox, T.M.

Volltext

In-depth phenotyping for clinical stratification of Gaucher disease von D'Amore, Simona, Page, Kathleen, Donald, Aimée, Taiyari, Khadijeh, Tom, Brian, Deegan, Patrick, Tan, Chong Y, Poole, Kenneth, Jones, Simon A, Mehta, Atul, Hughes, Derralynn, Sharma, Reena, Lachmann, Robin H, Chakrapani, Anupam, Geberhiwot, Tarekegn, Santra, Saikat, Banka, Siddarth, Cox, Timothy M

Volltext

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy von Platt, F. M., Jeyakumar, M., Andersson, U., Priestman, D. A., Dwek, R. A., Butters, T. D., Cox, T. M., Lachmann, R. H., Hollak, C., Aerts, J. M. F. G., Van Weely, S., Hrebícek, M., Moyses, C., Gow, I., Elstein, D., Zimran, A.

Volltext

Hereditary fructose intolerance von Ali, M, Rellos, P, Cox, T M

Volltext